[
  {
    "question": "Between optic tract and visual cortex:",
    "option_a": "Lateral geniculate body",
    "option_b": "Medial geniculate body",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuroophthalmology",
    "explanation": "The visual pathway involves the transmission of information from the retina to the visual cortex. After the optic tract, visual signals are relayed in the thalamus by the lateral geniculate body (nucleus), which is the primary relay station for visual data before it is sent to the occipital lobe. Damage to the lateral geniculate body (LGN) can disrupt the flow of visual information and result in characteristic visual field defects. The LGN is highly organized into layers that separately process input from each eye, maintaining the retinotopic map of the visual field. Lesions in the LGN can produce visual field deficits such as homonymous hemianopia. Patients might also present with decreased visual acuity or other visual disturbances. A careful visual field exam coupled with neuroimaging assists in localizing the lesion. Differential diagnoses include optic tract lesions, lesions in the optic radiations, and occipital lobe pathology. Visual field testing, along with MRI, helps in differentiating these lesions and pinpointing the exact site of the dysfunction within the visual pathway. Management focuses on addressing the underlying cause of the lesion, whether it be vascular, demyelinating, or neoplastic. In cases of ischemic injury, stroke guidelines including antiplatelet therapy and risk factor modification are applied. For demyelinating diseases, corticosteroids and subsequent immunomodulatory therapies are used, with careful assessment of medication safety in pregnancy and lactation. Option A (Lateral geniculate body) is correct because it serves as the relay station between the optic tract and the visual cortex. Option B (Medial geniculate body) is incorrect as it is part of the auditory pathway rather than the visual pathway. \u2022 The lateral geniculate body is essential for relaying and processing visual information from both eyes.  \u2022 A clear distinction should be made between LGN (visual) and MGN (auditory) in neuroanatomical localization. Advances in neuroimaging and functional MRI have further delineated the role of the LGN in visual processing. Updated stroke and demyelination guidelines continue to emphasize early intervention and tailored therapy, particularly when managing patients who are pregnant or lactating.",
    "exam_year": "2018",
    "exam_type": "Promotion"
  },
  {
    "question": "Localization of INO",
    "option_a": "Pon",
    "option_b": "Medulla",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuroophthalmology",
    "explanation": "Internuclear ophthalmoplegia (INO) is caused by a lesion affecting the medial longitudinal fasciculus (MLF), a neural tract that coordinates conjugate horizontal eye movements. The MLF is most commonly located in the dorsal pontine tegmentum, which explains why INO is typically localized to the pons. The MLF carries signals from the abducens nucleus to the contralateral oculomotor nucleus. Demyelinating diseases (such as multiple sclerosis in young adults) or cerebrovascular insults (in older adults) can damage this tract. In cases of acute demyelination or ischemia, the interruption of this pathway results in impaired adduction of the ipsilateral eye with compensatory nystagmus of the contralateral abducting eye. Patients with INO typically present with diplopia (double vision) and an inability to adduct one eye on lateral gaze. During an attempted lateral gaze, the abducting eye may show nystagmus while the adducting eye fails to move past the midline. These clinical findings correlate directly with a lesion in the MLF in the pons. Diagnosis is primarily clinical. Imaging with MRI can localize the lesion and help distinguish between demyelinating, ischemic, or other rare etiologies. Differential diagnoses include lesions in the midbrain affecting the MLF; however, the majority of cases are pontine in origin. Other conditions causing diplopia (such as cranial nerve palsies from mass lesions) can be ruled out with appropriate imaging and clinical findings. Management is guided by the underlying cause. In cases of multiple sclerosis, high-dose corticosteroids are used for acute exacerbations, whereas in ischemic stroke, management focuses on vascular risk factor control and supportive care. In pregnant or lactating women, treatment is tailored carefully: for example, corticosteroids are used cautiously with consideration of risks and benefits, and alternative therapies may be considered. Rehabilitation and symptomatic management (such as prism glasses for diplopia) may also be useful. Option A (Pon) is correct because the classic localization for an INO is in the pons where the MLF is most vulnerable. Option B (Medulla) is incorrect as the MLF is not located in the medulla in the context of INO. 1) INO is a hallmark in the differential diagnosis of diplopia, especially in younger patients with suspected multiple sclerosis. 2) The abducting nystagmus seen in INO is compensatory. 3) Neuroimaging with MRI is essential to confirm the brainstem lesion and exclude other etiologies. Recent studies continue to validate the role of high-resolution MRI in detecting MLF lesions. Updated guidelines emphasize individualized treatment based on the underlying pathology, with steroids remaining the first-line therapy for demyelinating causes, even in pregnant women after careful risk\u2010benefit analysis.",
    "exam_year": "2018",
    "exam_type": "Promotion"
  },
  {
    "question": "Typical scenario IIH. Attached CT and fundoscopy pictures.",
    "option_a": "(Brain tumor/mass lesion): Incorrect because IIH requires normal neuroimaging. \u2022 Option B (Venous sinus thrombosis): Incorrect since this is a secondary cause of raised ICP. \u2022 Option C (Normal fundoscopy): Incorrect because papilledema is usually present in IIH, unless in the rare IIHWOP (without papilledema) variant. \u2022 Option D (Hydrocephalus): Incorrect since ventriculomegaly is absent in IIH. The correct response is 'None' of these options apply.",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "None",
    "subspecialty": "Neuroophthalmology",
    "explanation": "Idiopathic Intracranial Hypertension (IIH) is characterized by raised intracranial pressure (ICP) without an identifiable mass lesion on neuroimaging. It most commonly affects obese women of childbearing age and is diagnosed after other causes have been excluded. The exact mechanism of IIH is not completely understood but is thought to result from impaired cerebrospinal fluid (CSF) absorption at the arachnoid granulations, possibly combined with increased cerebral venous pressure. Secondary causes of raised ICP, such as venous sinus thrombosis or hydrocephalus, must be ruled out before confirming the diagnosis as idiopathic. Patients with IIH typically present with symptoms of raised ICP such as headache, transient visual obscurations, and tinnitus. Fundoscopy usually reveals bilateral papilledema, a cardinal sign of increased ICP. The scenario with supporting CT and fundoscopy images strongly suggests IIH, provided no other abnormalities (like masses or ventricular enlargement) are present. The workup includes neuroimaging (MRI with MR venography) to rule out structural lesions and sinus thrombosis. A lumbar puncture showing an elevated opening pressure with normal CSF composition confirms the diagnosis of IIH. Differential diagnoses include brain tumors, venous sinus thrombosis, normal-tension papilledema (if fundoscopy were normal, which would be atypical) and hydrocephalus. The first-line management of IIH is weight loss and medical therapy with carbonic anhydrase inhibitors (such as acetazolamide). In refractory cases, second-line treatments including loop diuretics (e.g., furosemide) or surgical interventions like optic nerve sheath fenestration or CSF shunting may be considered. In pregnancy, acetazolamide is classified as category C and is generally avoided in the first trimester when possible; weight management and close monitoring are essential. Lactating mothers can use acetazolamide with caution, considering the benefits versus potential risks. \u2022 Option A (Brain tumor/mass lesion): Incorrect because IIH requires normal neuroimaging. \u2022 Option B (Venous sinus thrombosis): Incorrect since this is a secondary cause of raised ICP. \u2022 Option C (Normal fundoscopy): Incorrect because papilledema is usually present in IIH, unless in the rare IIHWOP (without papilledema) variant. \u2022 Option D (Hydrocephalus): Incorrect since ventriculomegaly is absent in IIH. The correct response is 'None' of these options apply. 1) Papilledema is a vital sign of IIH and must be carefully looked for. 2) Neuroimaging is essential to rule out other causes of raised ICP before diagnosing IIH. 3) Weight management is a cornerstone of management. Current research underlines the importance of early diagnosis and intervention in IIH to prevent permanent vision loss. Guidelines continue to support acetazolamide as first-line therapy, with recent studies focusing on the long-term impact of weight reduction strategies and the safety of medical therapies in pregnancy and lactation.",
    "exam_year": "2018",
    "exam_type": "Promotion"
  },
  {
    "question": "Central nystagmus vs peripheral there will be:",
    "option_a": "torsional horizontal",
    "option_b": "Absent latency",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Neuroophthalmology",
    "explanation": "Nystagmus is an involuntary, rhythmic oscillation of the eyes. Differentiating between central and peripheral nystagmus is critical because it guides further evaluation. Central nystagmus is often due to lesions within the central nervous system (brainstem or cerebellum), whereas peripheral nystagmus originates from disorders affecting the vestibular apparatus. In peripheral vestibular lesions, the nystagmus typically exhibits a brief latency period after a change in head position, is more intense when looking in the direction of the fast phase, and tends to fatigue on repeated testing. In contrast, central nystagmus appears without latency, tends not to fatigue, may change direction depending on gaze, and is not suppressed with visual fixation due to involvement of the central ocular motor control pathways. Patients with central causes of nystagmus, such as cerebellar or brainstem strokes, often lack the latency seen in peripheral forms. They may also present with other neurological signs (e.g., dysmetria, ataxia) which help distinguish central from peripheral etiologies. The evaluation of nystagmus involves a thorough clinical examination, including the head impulse test, evaluation of fixation suppression, and an assessment of accompanying neurological deficits. Differential diagnoses include peripheral vestibulopathies (like vestibular neuritis) and central lesions (such as cerebellar infarcts). Neuroimaging is warranted when central features are suspected. Management depends on the underlying cause. Peripheral causes may be treated with vestibular suppressants and physical therapy, while central causes necessitate further neuroimaging and specific treatment depending on the diagnosis (e.g., stroke management, demyelinating disease therapy). In pregnancies where medication is considered, options are chosen carefully to minimize fetal risk, and nonpharmacologic strategies such as vestibular rehabilitation are favored when possible. Option B, 'Absent latency,' is correct for central nystagmus, as central lesions characteristically show no delay in the onset of nystagmus. Other features distinguishing central from peripheral nystagmus include direction-changing behavior and lack of improvement with visual fixation. 1) Central nystagmus is typically non-fatigable and does not improve with fixation. 2) A careful head impulse test can help differentiate between central and peripheral causes. 3) Always look for other neurological signs that may indicate a central pathology. Recent clinical research supports the use of detailed bedside examination techniques to distinguish between central and peripheral nystagmus. Guidelines recommend urgent neuroimaging for patients with signs of central involvement to identify potentially life-threatening conditions.",
    "exam_year": "2018",
    "exam_type": "Promotion"
  },
  {
    "question": "Lesion of facial nerve in Stylomastoid foramina lead to:",
    "option_a": "absent gag reflex",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Neuroophthalmology",
    "explanation": "The facial nerve (CN VII) is responsible for motor innervation to the muscles of facial expression. Its course through the temporal bone, exiting via the stylomastoid foramen, is a critical point where isolated motor deficits can occur. A lesion at the level of the stylomastoid foramen typically affects the fibers responsible for facial muscle movement. Importantly, at this point the nerve has already given off branches that mediate taste (chorda tympani), lacrimation (greater petrosal nerve), and stapedius muscle function. Thus, a lesion here results in paralysis of the muscles of facial expression while largely sparing taste and lacrimation. Patients with a lesion of the facial nerve at the stylomastoid foramen usually present with a unilateral lower motor neuron facial palsy. This manifests as an inability to wrinkle the forehead, incomplete eye closure (lagophthalmos), and drooping of the corner of the mouth. The absence of involvement of the glossopharyngeal or vagus nerves means that the gag reflex remains intact. Clinical examination is paramount. The distinction between central (upper motor neuron) and peripheral (lower motor neuron) facial palsies is made by noting that central lesions spare the forehead. Differential diagnoses include Bell\u2019s palsy (idiopathic facial nerve palsy), Ramsay Hunt syndrome (if vesicles are present), and other rarer causes such as Lyme disease. Electroneurography and imaging (MRI) can be used if atypical features are present. Bell\u2019s palsy is the most common cause of a peripheral facial nerve palsy. First-line management typically involves corticosteroids to reduce nerve inflammation, ideally initiated within 72 hours of symptom onset. Antiviral therapy is sometimes added if a herpetic etiology is suspected. In pregnant or lactating individuals, steroids are used with careful consideration of risks and benefits, with dose adjustments as necessary and close monitoring. Eye care to prevent corneal drying is essential in cases of incomplete eye closure. Option A ('absent gag reflex') is incorrect because the gag reflex is mediated by CN IX and X, not the facial nerve. Option B, although not explicitly detailed, presumably refers to the expected presentation of an isolated peripheral facial paresis (loss of facial expression while sparing taste and lacrimation), which is correct for a lesion at the stylomastoid foramen. 1) A lesion at the stylomastoid foramen results in complete ipsilateral facial paralysis involving both the upper and lower face. 2) Preservation of taste and lacrimation helps localize the lesion to a point distal to the branching of these fibers. 3) Early steroid administration improves outcomes in Bell\u2019s palsy. Recent updates in clinical guidelines reinforce early treatment with corticosteroids for Bell\u2019s palsy, with evidence showing improved recovery rates. Ongoing research also emphasizes the importance of eye protection and the potential benefits of antiviral medications in select cases, while highlighting the need for individualized treatment plans in special populations such as pregnant and lactating women.",
    "exam_year": "2018",
    "exam_type": "Promotion"
  },
  {
    "question": "patient after minor trauma was reading news paper presented with diplopia, worse when the patient looks down & left, the outer image came from right eye what is the muscle affected:",
    "option_a": "Right Superior oblique.",
    "option_b": "Left superior oblique.",
    "option_c": "Right inferior oblique.",
    "option_d": "Left inferior oblique.",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuroophthalmology",
    "explanation": "Diplopia that worsens when looking down and to the left, especially after minor trauma, is suggestive of a cranial nerve IV (trochlear nerve) palsy. The superior oblique muscle, innervated by CN IV, is primarily responsible for intorsion and depression of the eye, particularly when it is adducted during reading or descending stairs. Trauma\u2014even if minor\u2014can injure the trochlear nerve because of its long intracranial course and thin structure. Damage to CN IV results in dysfunction of the superior oblique muscle, leading to an inability to appropriately depress and intort the affected eye. This misalignment causes vertical diplopia, as the affected eye drifts upward (hypertropia), with the patient perceiving one image as 'outer' due to the misdirected gaze. Patients with CN IV palsy often complain of vertical or oblique diplopia that worsens on downgaze (e.g., reading or descending stairs) and may adopt a compensatory head tilt away from the affected side. In this case, the right superior oblique muscle involvement explains the clinical finding that the outer image comes from the right eye during downward and left gaze. The clinical evaluation includes a detailed ocular motility exam, the Bielschowsky head tilt test (where tilting the head to either side accentuates or minimizes the diplopia), and sometimes imaging if a central lesion is suspected. Differential diagnoses include CN III palsy and skew deviation, but the pattern of worsening on downgaze and the typical head tilt help differentiate CN IV palsy. Management is usually conservative. Options include prism glasses to help realign vision and sometimes patching. Physical therapy or, in persistent cases, strabismus surgery might be considered. In pregnant or lactating patients, conservative management is favored to avoid surgical interventions unless absolutely necessary. Option A (Right Superior oblique) is correct because it explains the diplopia in downward gaze, especially after minor trauma. Option B (Left superior oblique) is incorrect because the displaced or 'outer' image originates from the right eye. Options C and D involve the inferior oblique muscles, which are primarily responsible for elevation and extorsion, not the depression function impaired in this case. 1. CN IV palsy is one of the most common cranial nerve injuries following minor head trauma. 2. A compensatory head tilt away from the affected side is a typical clinical finding. 3. Diplopia worsening on downgaze is highly suggestive of superior oblique dysfunction. Recent literature emphasizes the importance of a thorough neuro-ophthalmologic examination and advocates for early neuroimaging in atypical or non-traumatic cases. Conservative management with prisms is recommended initially, with surgery reserved for chronic, significant diplopia refractory to non-invasive methods.",
    "exam_year": "2019",
    "exam_type": "Promotion"
  },
  {
    "question": "horizontal nystagmus in the primary gaze each 90 sec, what is the Dx:",
    "option_a": "Periodic alternating nystagmus.",
    "option_b": "Acquired pendular nystagmus.",
    "option_c": "See saw nystagmus.",
    "option_d": "is not provided.",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuroophthalmology",
    "explanation": "Horizontal nystagmus that alternates direction periodically is indicative of a central ocular motor control dysfunction. Periodic alternating nystagmus (PAN) is characterized by nystagmus that reverses its direction in a cyclical fashion. The underlying mechanism for PAN is believed to be an instability or dysfunction of the neural integrator in the brainstem and cerebellum, which is responsible for holding the gaze in a fixed position. Lesions in the cerebellar or brainstem areas can disrupt these circuits, leading to cyclic changes in nystagmus direction. Patients with PAN often present with oscillopsia (a sensation of the visual field moving) and blurred vision. The periodic reversal\u2014here noted at around every 90 seconds\u2014is characteristic and helps distinguish it from other types of nystagmus. The differential diagnosis includes acquired pendular nystagmus (often seen in multiple sclerosis or brainstem pathology) and see-saw nystagmus (associated with parasellar or third ventricular lesions). A detailed history and neuro-ophthalmologic exam, often supplemented by imaging of the brain (especially the cerebellum and brainstem), are essential for accurate diagnosis. Management is tailored to the underlying etiology. First-line treatments may include medications such as baclofen, memantine, or gabapentin aimed at reducing nystagmus amplitude and frequency. In cases where an underlying lesion is identified, treatment of the primary pathology is necessary. In pregnant or lactating patients, careful consideration of medication safety profiles is essential; non-pharmacological strategies or therapies with established safety profiles in pregnancy are preferred. Option A (Periodic alternating nystagmus) is correct, as the description of horizontal nystagmus reversing direction every 90 seconds is typical of PAN. Option B (Acquired pendular nystagmus) presents with a similar appearance but lacks the periodic directional reversal. Option C (See-saw nystagmus) involves a combined vertical and torsional movement that is not described in this case. Option D is not provided. 1. The cyclical nature of PAN (approximately 90-second intervals) is its hallmark. 2. PAN usually has a central (brainstem/cerebellar) origin. 3. Differentiation from other nystagmus types based on pattern and periodicity is critical for management. Recent studies and guidelines suggest that treatment directed at stabilizing the neural integrator with medications like baclofen can be effective. Novel approaches and further research continue to refine pharmacological strategies in managing central nystagmus, while neuroimaging remains a cornerstone for ruling out structural lesions.",
    "exam_year": "2019",
    "exam_type": "Promotion"
  },
  {
    "question": "patient with BPPV, what is the management:",
    "option_a": "Epley maneuver",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuroophthalmology",
    "explanation": "Benign Paroxysmal Positional Vertigo (BPPV) is a common peripheral vestibular disorder caused by dislodged otoconia from the utricle entering the semicircular canals. Patients typically experience brief episodes of vertigo triggered by head position changes. In BPPV, calcium carbonate crystals (otoconia) become dislodged from the utricle and migrate into the semicircular canals, most commonly the posterior canal. These particles cause abnormal endolymph fluid displacement when the head moves, leading to a mismatch in sensory input and the sensation of vertigo. Patients often report vertigo with changes in head position, such as looking up, bending over, or rolling over in bed. The Dix-Hallpike maneuver is the standard diagnostic test, which typically reproduces vertigo and induces a characteristic torsional nystagmus. The differential diagnosis includes Meniere's disease, vestibular neuritis, and central causes of vertigo (e.g., cerebellar stroke). A detailed history, physical examination (including Dix-Hallpike maneuver), and sometimes vestibular testing can help differentiate these conditions. First-line management of BPPV is the use of canalith repositioning maneuvers such as the Epley maneuver, which is highly effective in relocating the displaced otoconia. For patients who are pregnant or lactating, these maneuvers are safe since they do not involve medications or invasive procedures. If repositioning maneuvers fail, vestibular rehabilitation and, in rare cases, surgical interventions may be considered. Option A (Epley maneuver) is correct as it is the standard first-line treatment for BPPV. Other options are either not provided or not standard approaches to BPPV management. 1. BPPV is the most common cause of vertigo and is often effectively treated with simple repositioning maneuvers. 2. The Dix-Hallpike maneuver is key in diagnosing BPPV. 3. Canalith repositioning is safe and effective, including in pregnant and lactating patients. Current guidelines strongly recommend canalith repositioning maneuvers like the Epley maneuver as first-line treatment for BPPV. Ongoing research continues to optimize these maneuvers and evaluate adjunct therapies, but repositioning remains the cornerstone of management.",
    "exam_year": "2019",
    "exam_type": "Promotion"
  },
  {
    "question": "Patient with binocular diplopia, vertical image from right eye, the diplopia worsen with reading or when he look down to the right side, which CN affected:",
    "option_a": "Right abducens",
    "option_b": "Right Superior oblique muscle",
    "option_c": "Left Superior oblique muscle",
    "option_d": "Right oculomotor",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Neuroophthalmology",
    "explanation": "Binocular diplopia with a vertical misalignment, especially when it worsens during reading or when looking down and to the right, suggests involvement of a muscle responsible for depressing the eye in positions of adduction. The superior oblique muscle, innervated by the trochlear nerve (CN IV), is primarily responsible for this action in the affected eye. A palsy of the superior oblique muscle (right side in this scenario) results from impairment of the trochlear nerve. This leads to an inability to properly depress and intort the right eye, causing it to drift upward (hypertropia). The vertical separation of images arises because the affected eye is not correctly aligned with the healthy eye, resulting in diplopia that worsens when the patient is reading or looking down, when the superior oblique should be most active. In a right CN IV palsy, the patient experiences vertical diplopia, with the misaligned (right) eye producing a displaced or 'vertical' image. The worsening of symptoms during reading or when looking down and to the right is consistent with the impaired function of the right superior oblique muscle. Patients often adopt a head tilt away from the affected side to compensate for the diplopia. The evaluation involves a detailed history and ocular motility examination, including the Bielschowsky head tilt test to assess for changes in the diplopia with head position. Differential diagnoses include other causes of vertical diplopia such as CN III palsy (which would also affect other extraocular movements) and myasthenia gravis (characterized by fatigable muscle weakness), but these are distinguished by their broader range of symptoms and different patterns of ocular misalignment. Initial management is conservative, including the use of prism glasses to ameliorate diplopia and sometimes patching of one eye. In persistent cases, strabismus surgery may be considered. During pregnancy and lactation, non-invasive management is preferred; surgical interventions, if necessary, are deferred until postpartum or managed in consultation with a multidisciplinary team considering the risks. Option A (Right abducens) is incorrect since a CN VI palsy typically results in horizontal diplopia due to lateral rectus weakness. Option B (Right Superior oblique muscle) is correct because it directly corresponds to the clinical picture of vertical diplopia on downgaze resulting from a right CN IV palsy. Option C (Left Superior oblique muscle) is incorrect because the right eye (producing the vertical image) is affected, not the left. Option D (Right oculomotor) is incorrect as a CN III palsy would lead to multiple deficits (ptosis, pupillary changes, and an 'out and down' position) rather than isolated vertical diplopia. 1. A right CN IV palsy typically presents with vertical diplopia that worsens in downgaze and reading positions. 2. Patients may exhibit a compensatory head tilt away from the affected side to minimize diplopia. 3. Isolated trochlear nerve palsy is most common after minor head trauma. Recent studies underscore the importance of detailed neuro-ophthalmologic examinations, including specialized ocular motility tests, in diagnosing trochlear nerve palsy. Current guidelines favor conservative management for mild cases, with prism correction as first-line therapy. When surgical intervention is needed, the timing and approach are carefully considered, particularly in vulnerable populations such as pregnant and lactating patients.",
    "exam_year": "2022",
    "exam_type": "Promotion"
  },
  {
    "question": "Which of the following thalamic structures connects the optic tracts to the visual cortex:",
    "option_a": "Lateral geniculate",
    "option_b": "Pulvinar nucleus",
    "option_c": "Medial geniculate",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuroophthalmology",
    "explanation": "The lateral geniculate nucleus (LGN) is the principal relay center in the thalamus for the visual pathway. Retinal ganglion cells send information via the optic tracts to the LGN, which then projects through the optic radiations to the primary visual cortex. Understanding this pathway is essential for neuroanatomy and explains how visual signals are transmitted from the eyes to the occipital lobe. At the cellular level, the LGN receives segregated input from the magnocellular and parvocellular retinal pathways, which process motion and detailed color/form information, respectively. Damage or vascular events affecting the LGN can disrupt these modalities. Moreover, the LGN is subject to both feed-forward input from the retina and feedback modulation from the visual cortex, underscoring its integrative role in visual processing as shown in current neuroimaging studies. Lesions anywhere along the visual pathway produce characteristic deficits. A lesion involving the LGN (or damage in its vicinity) can result in visual field deficits such as contralateral homonymous hemianopia. Recognizing that the LGN serves as the conduit to the visual cortex explains why its involvement directly affects visual perception. When a patient presents with a visual field defect, visual field testing (perimetry) is critical in localizing the lesion. Neuroimaging (MRI with attention to the thalamus and optic radiations) helps distinguish between optic nerve, chiasmal, tract, LGN, or cortical lesions. Differential diagnoses include optic neuritis, ischemic optic neuropathy, and lesions of the optic radiations. Management of pathologies involving the LGN is generally determined by the underlying cause. In ischemic events (such as thalamic strokes), early recognition and adherence to stroke protocols (including possible thrombolysis) are essential. In demyelinating conditions (like multiple sclerosis) involving the thalamus, corticosteroids may be used in an acute relapse. For pregnant or lactating patients, treatment decisions must weigh benefits and risks; for example, MRI is generally considered safe without contrast, and thrombolytic decisions follow modified stroke guidelines applicable to pregnancy. Option A (Lateral geniculate) is correct because this nucleus is the specific thalamic structure that receives input from the optic tracts and relays it to the visual cortex. Option B (Pulvinar nucleus) is mostly involved in higher order visual processing and attention but is not the primary relay for visual signals. Option C (Medial geniculate) is part of the auditory pathway, not vision. Option D is blank and not applicable. \u2022 The LGN is a key relay station in the afferent visual pathway. \u2022 Distinguishing between the lateral and medial geniculate nuclei is critical since they serve different sensory modalities. \u2022 Lesions of the LGN can produce contralateral visual field deficits consistent with its anatomical location. Recent advancements in functional MRI and diffusion tensor imaging have refined our understanding of thalamic connectivity. Updated stroke guidelines emphasize rapid imaging of the thalamus and occipital regions in suspected posterior circulation strokes to optimize outcomes.",
    "exam_year": "2023",
    "exam_type": "Promotion"
  },
  {
    "question": "Right occipital with visual field defect. What could come with this condition?",
    "option_a": "Visual anosognosia",
    "option_b": "Optic ataxia",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "None",
    "subspecialty": "Neuroophthalmology",
    "explanation": "The occipital lobe, particularly its primary visual cortex, is responsible for processing visual information. A lesion in the right occipital lobe typically results in a left homonymous hemianopia with macular sparing\u2014a classic finding in posterior cerebral artery (PCA) territory strokes. Associated syndromes depend on lesion extent and involvement of adjacent regions. Right occipital infarcts, often due to occlusion of the PCA, lead to loss of visual field input from the contralateral (left) hemifield. The specific visual deficits depend on whether only the primary visual cortex is involved or if the lesion extends into adjacent visual association areas. Anton syndrome (visual anosognosia) requires bilateral occipital involvement leading to cortical blindness with denial of deficits, whereas optic ataxia is typically a sign of dorsal stream dysfunction (usually involving the parietal lobe). In a patient with a right occipital lesion, the key clinical manifestation is a visual field defect (left homonymous hemianopia, often with macular sparing). Additional symptoms such as visual anosognosia (Anton syndrome) are classically seen with bilateral occipital lesions, and optic ataxia is associated with lesions affecting the parieto\u2010occipital junction (as seen in Balint syndrome). Neither of these is a typical accompaniment of an isolated right occipital injury. Evaluation begins with a thorough visual field assessment (perimetry) to delineate the extent of the defect. Neuroimaging (CT/MRI) is used to localize the lesion within the PCA territory. Differential diagnoses include other causes of visual field cut (e.g., optic nerve/tract lesions) and other stroke syndromes like Balint syndrome when additional deficits (optic ataxia, ocular apraxia, simultanagnosia) are suspected. The presence or absence of denial of visual loss helps differentiate between Anton syndrome and simple visual field defects. The management of occipital strokes follows acute stroke protocols including rapid revascularization (thrombolysis or thrombectomy) as eligible. Long-term management focuses on secondary stroke prevention, visual rehabilitation, and sometimes compensatory strategies for persistent field deficits. In pregnant or lactating patients, thrombolytic therapy and imaging choices must be carefully weighed; MRI is preferred over CT when feasible to reduce radiation exposure, and medications used for stroke prevention should be evaluated for safety in these populations. \u2022 Option A (Visual anosognosia) describes a condition (Anton syndrome) where patients are unaware of their cortical blindness, but this syndrome is typically seen with bilateral occipital lobe lesions rather than an isolated right occipital lesion. \u2022 Option B (Optic ataxia) is more aligned with dorsal stream dysfunction (often part of Balint syndrome) typically resulting from bilateral parieto\u2010occipital lesions, not an isolated occipital injury. \u2022 Options C and D are blank. Therefore, none of the provided options appropriately describe an expected associated feature of an isolated right occipital lesion with a visual field defect. \u2022 An isolated right occipital lesion most commonly produces a left homonymous hemianopia with macular sparing. \u2022 Anton syndrome (visual anosognosia) requires bilateral occipital damage; unilateral lesions are unlikely to produce denial of visual loss. \u2022 Optic ataxia is typically linked to dorsal stream (parietal) involvement and not seen with pure occipital lesions. Recent stroke guidelines highlight the importance of early identification and treatment of PCA infarcts. Contemporary neuroimaging studies have helped differentiate the syndromes resulting from lesions in distinct areas of the posterior circulation, clarifying that Anton syndrome demands extensive bilateral involvement while optic ataxia requires dorsal visual pathway compromise.",
    "exam_year": "2023",
    "exam_type": "Promotion"
  },
  {
    "question": "Patient known to have psychiatric symptoms on antipsychotics medication for long time presented with face and tongue abnormal movement what is the diagnosis:",
    "option_a": "Tardive dyskinesia",
    "option_b": "Autoimmune",
    "option_c": "Neuroleptic malignant syndrome",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Movement Disorders",
    "explanation": "Tardive dyskinesia is a movement disorder characterized by involuntary, repetitive movements\u2014most commonly involving the face, tongue, and sometimes the extremities\u2014that usually develops after long\u2010term exposure to dopamine receptor blocking agents such as antipsychotics. The mechanism is thought to relate to dopamine receptor upregulation and hypersensitivity in the basal ganglia following chronic blockade by antipsychotic medications. This leads to abnormal involuntary motor output. Recent evidence continues to support the role of altered striatal gamma-aminobutyric acid (GABA) and neuroplastic changes within extrapyramidal circuits. Patients present with abnormal, involuntary movements (e.g., lip smacking, tongue protrusion, grimacing) that are typically choreoathetoid in nature. The fact that these symptoms occur after prolonged antipsychotic treatment aids in clinching the diagnosis of tardive dyskinesia. Diagnosis is largely clinical, based on history\u2014particularly long-term antipsychotic use\u2014and the pattern of involuntary movements. Differential diagnoses include acute drug-induced movement disorders (e.g., dystonia or akathisia), primary movement disorders (like Huntington\u2019s disease), and other medication-induced dyskinesias. A detailed medication history and neurological examination are crucial. First-line management involves reducing the dose or discontinuing the offending agent if possible, or switching to atypical antipsychotics with a lower propensity for this side effect. VMAT2 inhibitors (such as valbenazine or deutetrabenazine) have received approval for moderate-to-severe cases. Supportive treatments and regular monitoring are essential. In pregnant or lactating patients, the risk\u2013benefit balance of any medication adjustments must be carefully considered, with consultation from specialists in maternal\u2013fetal medicine when modifying antipsychotic therapy. Option A (Tardive dyskinesia) is correct since the presentation of facial and tongue abnormal movements after long-term antipsychotic therapy is characteristic. Option B (Autoimmune) is not consistent with the temporal relationship or the typical movement pattern. Option C (Neuroleptic malignant syndrome) is an acute, life\u2010threatening syndrome marked by rigidity, hyperthermia, and autonomic disturbances\u2014not the tardive, involuntary, dyskinetic movements seen here. 1) Tardive dyskinesia typically presents after prolonged exposure to antipsychotics and manifests with orofacial dyskinesias. 2) Early detection is important to prevent progression. 3) VMAT2 inhibitors are now recognized as an effective treatment option. Recent guidelines emphasize regular screening for tardive dyskinesia in patients receiving dopamine receptor blockers and advocate for the use of newer agents like VMAT2 inhibitors. Ongoing research into neuroprotective strategies is promising but has yet to alter current management paradigms significantly.",
    "exam_year": "2018",
    "exam_type": "Part I"
  },
  {
    "question": "What is the most commonly presents with apathy in these disorders?",
    "option_a": "PSP",
    "option_b": "Parkinson disease",
    "option_c": "FTD",
    "option_d": "MSA",
    "option_e": "",
    "correct_answer": "C",
    "subspecialty": "Movement Disorders",
    "explanation": "Frontotemporal dementia (FTD) is a neurodegenerative disorder that predominantly affects the frontal and anterior temporal lobes, leading to marked personality changes. Apathy is one of its core behavioral features alongside disinhibition. FTD is characterized by the abnormal accumulation of proteins such as tau or TDP-43 within neurons, leading to selective neuronal loss in the frontal and temporal lobes. This degeneration disrupts circuits involved in motivation, social behavior, and executive function, which explains the early and prominent apathy. Patients with FTD typically present with marked changes in behavior and personality. Apathy, which is characterized by a diminished motivation and emotional indifference, is a hallmark of the behavioral variant of FTD, helping differentiate it from other neurodegenerative disorders that may primarily affect memory or motor function. Diagnosis is based on clinical history, neuropsychological testing, and neuroimaging which typically shows frontal and temporal lobe atrophy. Differential diagnoses include Progressive Supranuclear Palsy (PSP), Parkinson\u2019s disease (which may have apathy but with prominent motor symptoms), and Multiple System Atrophy (MSA) where autonomic dysfunction is key. The pattern of cognitive and behavioral deficits helps differentiate FTD from Alzheimer\u2019s disease and other dementias. Management is largely symptomatic and supportive. Although there is no cure, behavioral interventions, structured environments, and sometimes selective serotonin reuptake inhibitors (SSRIs) may help manage symptoms. In pregnant or lactating patients (rare in FTD given the typical age of onset), medication choices (like SSRIs) must be carefully reviewed for teratogenic risk and neonatal adaptation. Option A (PSP) is better known for vertical gaze palsy and frequent falls, while Option B (Parkinson disease) primarily presents with motor symptoms and may develop apathy later. Option D (MSA) is characterized by significant autonomic dysfunction. Option C (FTD) is correct as it most commonly presents with early apathy and personality changes. 1) Apathy in FTD is often accompanied by social withdrawal and loss of empathy. 2) FTD typically presents in younger patients (50s-60s) than Alzheimer\u2019s disease. 3) Differentiating FTD from other dementias hinges on behavioral changes rather than memory loss early in the disease. Recent research continues to explore biomarkers (including imaging and cerebrospinal fluid markers) for early FTD diagnosis. There is ongoing investigation into disease-modifying therapies, though supportive care remains the mainstay of treatment.",
    "exam_year": "2018",
    "exam_type": "Part I"
  },
  {
    "question": "Regarding enhanced physiological tremor. Which is correct?",
    "option_a": "Tremor attenuation with alcohol",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Movement Disorders",
    "explanation": "Enhanced physiologic tremor refers to an increased amplitude of the normal physiological tremor. It occurs in various conditions such as anxiety, hyperthyroidism, use of certain medications (e.g., beta-agonists, caffeine), or metabolic disturbances. The normal physiologic tremor is typically subclinical but can be accentuated by conditions that increase neuromuscular excitability or adrenergic activity. Enhanced tremor is thought to result from increased central drive and/or peripheral factors that amplify the normally minimal, high-frequency oscillations found in motor units. Clinically, enhanced physiologic tremor presents as a fine, rapid, postural or action tremor. Its amplitude increases with stress, caffeine consumption, or medications that stimulate adrenergic receptors. Unlike essential tremor\u2014a distinct pathological entity which often improves with alcohol\u2014enhanced physiologic tremor usually resolves with treatment of the underlying cause. The diagnosis is clinical and is based on history and physical examination. Differential diagnoses include essential tremor (which is typically chronic and familial), drug-induced tremor, and tremors secondary to metabolic abnormalities like hyperthyroidism. A careful history to identify precipitating factors, medication review, and laboratory investigations (e.g., thyroid function tests) are critical. The primary management strategy is to identify and correct the underlying cause\u2014such as reducing caffeine intake, addressing anxiety, or treating hyperthyroidism. Beta-blockers, particularly propranolol, can be used to reduce tremor amplitude if symptomatic treatment is required. In pregnant or lactating patients, non-pharmacological interventions are preferred, and if beta-blockers are indicated, agents with a better safety profile in pregnancy (e.g., labetalol) may be considered after careful risk\u2013benefit assessment. Option A states 'Tremor attenuation with alcohol' which is a classic feature of essential tremor but is not the typical description for enhanced physiologic tremor; in fact, enhanced physiologic tremor is more related to metabolic or adrenergic factors. Although the exact phrasing of Option B is not provided, the marked answer (B) is assumed to contain the statement that best describes the characteristics of enhanced physiologic tremor (such as its exacerbation by caffeine, stress, and \u03b2-agonists, or its responsiveness to beta-blockers). Options C and D are not available for analysis. Based on the context, the marked answer (B) is considered correct. 1) Enhanced physiologic tremor is most apparent in conditions of increased stress or catecholamine release. 2) Unlike essential tremor, it is not typically a primary neurodegenerative disorder. 3) Management is focused on addressing the underlying cause rather than the tremor itself. Recent studies have reinforced the importance of identifying exogenous contributors (like caffeine and certain medications) in patients presenting with tremor. There is also an emphasis in current guidelines on differentiating enhanced physiologic tremor from essential tremor through careful history, clinical examination, and response to interventions such as beta-blockers rather than alcohol.",
    "exam_year": "2018",
    "exam_type": "Part I"
  },
  {
    "question": "History of elderly with frequent falls, limited vertical gaze, parkinsonian what is the diagnosis?",
    "option_a": "PSP",
    "option_b": "MSA",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Movement Disorders",
    "explanation": "Progressive supranuclear palsy (PSP) is a neurodegenerative disorder that presents with a predominant parkinsonian syndrome combined with distinctive oculomotor abnormalities and early postural instability, often resulting in frequent falls. PSP is characterized by the abnormal accumulation of tau protein (a 4-repeat tauopathy) in neurons and glial cells, particularly affecting the brainstem, basal ganglia, and frontal lobes. This pathological tau deposition leads to dysfunction in neural circuits that control eye movements, balance, and movement initiation. Patients with PSP typically develop early falls, axial rigidity, and notable difficulties with vertical gaze (especially downgaze limitation). These clinical findings, particularly in an elderly patient, are highly suggestive of PSP rather than more common conditions like idiopathic Parkinson\u2019s disease, where early falls and gaze palsy are not typical. Diagnosis is primarily based on clinical criteria including a history of early falling, symmetrical parkinsonism, and vertical gaze palsy. Differential diagnoses include Parkinson disease (which usually has a resting tremor and asymmetry), Multiple System Atrophy (which features marked autonomic dysfunction), and corticobasal degeneration. Neuroimaging may aid in supporting the diagnosis (e.g., midbrain atrophy giving the 'hummingbird sign'). Management of PSP is largely supportive as there is no proven disease-modifying therapy. Physical and occupational therapy can help mitigate fall risk and maintain mobility. Medications such as levodopa are typically trialed, though responses are minimal. In cases when considering pharmacotherapy during pregnancy or lactation (which is rare given the typical age group), the safety profiles of the medications must be carefully considered, although these patients are generally older. Option A (PSP) is correct because the combination of frequent falls, vertical gaze palsy, and parkinsonism is pathognomonic for PSP. Option B (MSA) more commonly presents with prominent autonomic dysfunction and cerebellar features rather than vertical gaze limitation. The absence of details in Options C and D further supports that Option A is the appropriate choice. 1) Early postural instability and unexplained falls are a hallmark of PSP. 2) Vertical gaze palsy, especially difficulty with downgaze, is a key clinical sign. 3) PSP is generally unresponsive to levodopa, contrasting with idiopathic Parkinson disease. Recent updates in diagnostic criteria and neuroimaging (such as the hummingbird sign on MRI) have improved early detection of PSP. Current research continues to explore tau-targeting therapies, but no disease-modifying treatment is yet available, making supportive management the cornerstone of care.",
    "exam_year": "2018",
    "exam_type": "Part I"
  },
  {
    "question": "Elderly man with DM, HTN, CABG with no history of stroke came with progressive dementia over 6 months, and falls, on exam he had Parkinson\u2019s signs in distal lower limb, limited vertical gaze, MRI showed ischemic changes. What\u2019s the diagnosis?",
    "option_a": "Vascular parkinsonism",
    "option_b": "NPH",
    "option_c": "PD",
    "option_d": "PSP",
    "option_e": "",
    "correct_answer": "D",
    "subspecialty": "Movement Disorders",
    "explanation": "Progressive Supranuclear Palsy (PSP) is an atypical parkinsonian disorder characterized by early postural instability, frequent falls, and especially impaired vertical gaze. It is a neurodegenerative condition where patients develop parkinsonian signs combined with distinctive eye movement abnormalities. PSP is a tauopathy resulting from abnormal accumulation of tau protein within neurons and glia, particularly affecting the basal ganglia and brainstem (especially the midbrain). This tau accumulation leads to degeneration of key neuronal circuits involved in controlling eye movements and postural control. Although vascular risk factors and ischemic changes might be seen on imaging in elderly patients, the presence of vertical gaze limitation is most pathognomonic for PSP rather than vascular parkinsonism. Patients with PSP typically present with early falls, axial rigidity, bradykinesia, and a limited vertical range of eye movement (especially downgaze). The progressive dementia seen in some patients further supports the diagnosis. In contrast to classic Parkinson's disease, PSP patients have a poor response to levodopa and more rapid progression of gait and balance problems. The diagnosis is primarily clinical, supported by brain MRI showing midbrain atrophy (often presenting as the 'hummingbird sign'). Differential diagnoses include: \u2022 Vascular parkinsonism (characterized by lower-body predominance in parkinsonism and history of strokes), \u2022 Normal Pressure Hydrocephalus (typically shows gait apraxia with urinary incontinence and dementia but lacks eye movement abnormalities), and \u2022 Parkinson\u2019s disease (asymmetric onset with a good levodopa response). There is no curative therapy for PSP. Management is largely supportive and symptomatic: First-line treatments include physical therapy to maintain mobility and balance training; occupational and speech therapy may be beneficial for daily functioning. Pharmacologically, levodopa is sometimes trialed but usually with minimal response. In severe cases, palliative care and caregiver support are essential. (Pregnancy and lactation considerations are generally not applicable as PSP commonly affects the elderly.) Option A (Vascular parkinsonism) is less likely because it usually does not feature vertical gaze palsy. Option B (NPH) is characterized by gait apraxia, urinary incontinence, and cognitive decline but not by supranuclear gaze palsy. Option C (PD) typically presents with asymmetric motor features and responds more robustly to levodopa. Option D (PSP) is correct because the limited vertical gaze and early falls are classical hallmarks of the condition. \u2022 Vertical supranuclear gaze palsy is a key indicator of PSP. \u2022 Early frequent falls in an elderly patient with parkinsonian features should raise suspicion for PSP. \u2022 PSP is typically unresponsive to levodopa therapy. Recent research continues to explore biomarkers for early PSP diagnosis, including advanced neuroimaging techniques. Moreover, emerging studies on tau-targeting therapies are under investigation, although no definitive disease-modifying treatments for PSP currently exist.",
    "exam_year": "2018",
    "exam_type": "Part I"
  },
  {
    "question": "Patient came complaining of lower limbs tremor starts when she stands up and doesn\u2019t improve when he starts walking, he mentions that he has a relative with hand tremor when he holds the newspaper, EMG: (orthostatic tremor) what will you give him:",
    "option_a": "Propranolol",
    "option_b": "Levodopa",
    "option_c": "Clonazepam",
    "option_d": "",
    "option_e": "",
    "correct_answer": "C",
    "subspecialty": "Movement Disorders",
    "explanation": "Orthostatic tremor is a rare movement disorder characterized by a high-frequency tremor that predominantly affects the legs upon standing. It results in a feeling of unsteadiness and may lead to falls or difficulty standing. The underlying mechanism is thought to be due to abnormal oscillatory activity within central neural networks, possibly involving the cerebellum and brainstem. Electrophysiological studies, through EMG, typically demonstrate a high-frequency (around 13\u201318 Hz) rhythmic tremor, confirming the diagnosis. Patients commonly complain of tremors in the lower limbs that are prominent upon standing and may reduce slightly with walking. Despite familial history of other types of tremors (like essential tremor), the EMG pattern distinguishes orthostatic tremor from other tremor disorders. Diagnosis hinges on clinical observation supported by EMG findings. Differential diagnoses include essential tremor (which usually affects the hands and is evident during action or maintaining a posture) and other forms of postural tremor. Careful history and electrophysiologic studies are key in distinguishing orthostatic tremor. The first-line treatment for orthostatic tremor is Clonazepam, a benzodiazepine that helps reduce the high-frequency tremor. Second-line treatments may include gabapentin. In patients who are pregnant or lactating, the risks and benefits of clonazepam must be carefully weighed, as benzodiazepines have potential teratogenic effects (commonly categorized as FDA pregnancy category D) and risk neonatal withdrawal, so alternative strategies and specialist consultation are necessary. Option A (Propranolol) is typically used for essential tremor, not orthostatic tremor. Option B (Levodopa) is not indicated in orthostatic tremor. Option C (Clonazepam) is the correct choice as it is most effective in reducing the tremor intensity in this condition. \u2022 Orthostatic tremor presents with high-frequency lower limb tremor that is most prominent upon standing. \u2022 EMG confirmation is essential for diagnosis. \u2022 Clonazepam is the treatment of choice, but caution is warranted in pregnancy. Recent studies and clinical practice guidelines continue to endorse clonazepam as first-line therapy. Emerging evidence suggests that gabapentin may be an alternative in those intolerant to benzodiazepines, although further research is needed.",
    "exam_year": "2018",
    "exam_type": "Part I"
  },
  {
    "question": "Patient works as a chef he has been complaining of months history of upper limb resting tremor and rigidity, during exam was found to have unilateral bradykinesia and resting tremor, patient mentioned he has gambling problem what will you do:",
    "option_a": "carbidopa/levodopa",
    "option_b": "carbidopa/levodopa/entacapone",
    "option_c": "Dopamine antagonist",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Movement Disorders",
    "explanation": "Parkinson\u2019s disease (PD) is a neurodegenerative disorder marked by a classic triad of resting tremor, rigidity, and bradykinesia. It primarily results from dopamine deficiency in the nigrostriatal pathway. The degeneration of dopaminergic neurons in the substantia nigra pars compacta leads to a deficiency of dopamine in the striatum. This results in the classic motor symptoms of PD. The presence of Lewy bodies, composed of alpha-synuclein aggregates, is a pathological hallmark of the disease. Patients typically present with unilateral symptoms initially (such as resting tremor and bradykinesia) which gradually progress and become bilateral. The patient\u2019s mention of a gambling problem is significant because dopamine agonists are known to exacerbate impulse control disorders, making levodopa-based treatments more favorable. Diagnosis is clinical, based on history and physical examination findings. Differential diagnoses include atypical parkinsonism (such as PSP or multiple system atrophy), essential tremor, and drug-induced parkinsonism. The good response to levodopa is supportive of PD. First-line treatment for PD is Carbidopa/Levodopa, which is the most effective medication for controlling motor symptoms. Dopamine agonists are sometimes used in younger patients; however, due to the patient\u2019s history of a gambling problem (an indicator for impulse control disorders), levodopa is the preferred treatment. Second-line treatments or adjuvants include MAO-B inhibitors and, in later stages, COMT inhibitors such as entacapone. In pregnancy and lactation, levodopa is considered relatively safe compared to other dopaminergic therapies, though careful risk-benefit assessment is required. Option A (Carbidopa/Levodopa) is correct for PD management, especially in a patient at risk of impulse control disorders. Option B (Carbidopa/Levodopa/Entacapone) is typically reserved for patients with motor fluctuations and is not necessary initially. Option C (Dopamine antagonist) is contraindicated in PD as it can worsen motor symptoms. \u2022 Unilateral resting tremor and bradykinesia are hallmark early findings in PD. \u2022 Levodopa is the gold standard treatment, particularly when there are concerns about impulse control disorders. \u2022 Avoid dopamine agonists in patients with a history of addictive behaviors or impulse control issues. Recent guidelines advocate for the individualized use of levodopa therapy in PD, with emphasis on quality of life improvements. Advances in wearable technology for monitoring motor fluctuations and studies on early intervention strategies are continually updating PD management practices.",
    "exam_year": "2018",
    "exam_type": "Part I"
  },
  {
    "question": "Patient with PD on treatment presented with visual hallucination and agitation which antipsychotic will you give?",
    "option_a": "Risperidone",
    "option_b": "Quetiapine",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Movement Disorders",
    "explanation": "In Parkinson\u2019s disease, psychotic symptoms such as visual hallucinations may develop, often as a side effect of dopaminergic therapy. The selection of antipsychotics in PD must be cautious to avoid exacerbating motor symptoms. Visual hallucinations and agitation in PD are thought to arise from an imbalance in neurotransmitters, particularly due to excessive dopaminergic stimulation in the mesolimbic pathway while the nigrostriatal dopamine deficiency persists. Antipsychotics that block dopamine receptors can worsen motor symptoms. Quetiapine has lower D2 receptor affinity, making it more suitable in this context. Patients with PD who develop psychosis typically present with visual hallucinations, delusions, or agitation. It is important to distinguish whether these symptoms are due to disease progression or medication side effects. Its management often requires careful dose adjustments of antiparkinsonian medications along with appropriate antipsychotic therapy. The assessment involves a detailed review of the patient\u2019s medication regimen, neuropsychiatric evaluation, and ruling out other causes of acute psychosis. Differential diagnoses include dementia with Lewy bodies and primary psychotic disorders. Monitoring temporal association with dopaminergic therapy helps in distinguishing medication-induced psychosis. First-line management includes reducing or optimizing dopaminergic therapy if possible. When antipsychotic treatment is necessary, Quetiapine is preferred due to its minimal D2 receptor blockade and lower risk of worsening motor symptoms. Clozapine is another option, although its use is limited by the need for blood monitoring. In pregnant or lactating patients, the risks versus benefits of antipsychotic therapy must be carefully weighed; atypical antipsychotics are generally used at the lowest effective dose with close monitoring. Option A (Risperidone) is less ideal because its dopamine blockade can exacerbate parkinsonian motor symptoms. Option B (Quetiapine) is the correct answer because it is known to be safer in PD patients regarding motor function while effectively managing psychosis. \u2022 In PD, antipsychotic choice is crucial: select agents with minimal impact on dopamine receptors controlling motor function. \u2022 Visual hallucinations in PD are often medication-induced and should prompt a review of dopaminergic therapy. \u2022 Quetiapine is commonly used in PD psychosis due to its favorable side effect profile. Recent clinical guidelines and research continue to support the use of quetiapine for managing psychosis in PD. Emerging therapies, such as pimavanserin, are also being investigated for their efficacy and safety in PD psychosis, although quetiapine remains widely utilized in clinical practice.",
    "exam_year": "2018",
    "exam_type": "Part I"
  },
  {
    "question": "Regarding essential palatal myoclonus?",
    "option_a": "Disappear with sleep",
    "option_b": "Hypertrophy of ipsilateral olivary nucleus",
    "option_c": "Pathology involving triangle of mollaret.",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Movement Disorders",
    "explanation": "Essential palatal myoclonus (or essential palatal tremor) is a movement disorder characterized by rhythmic involuntary contractions of the palatal muscles. It is classified as a distinct entity that is not secondary to an identifiable structural lesion, unlike symptomatic palatal tremor. In essential palatal myoclonus there is no identifiable lesion in the dentato\u2010rubro\u2010olivary pathway (the Guillain\u2013Mollaret triangle). The pathogenesis is thought to involve a central oscillator leading to abnormal rhythmic contractions. In contrast, symptomatic palatal tremor is associated with lesions that cause hypertrophic degeneration of the inferior olivary nucleus. Patients with essential palatal myoclonus often experience audible clicking due to the contraction of muscles such as the tensor veli palatini. A hallmark feature is that the tremor typically disappears during sleep, distinguishing it from symptomatic forms where the involuntary movements may persist. The diagnosis is primarily clinical. Brain MRI is useful in differentiating essential from symptomatic palatal tremor. In symptomatic cases, imaging may reveal hypertrophy and signal changes in the inferior olive and involvement of the Guillain\u2013Mollaret triangle. Differential diagnoses include other causes of myoclonus such as epileptic myoclonus or tardive dyskinesia. Management of essential palatal myoclonus is usually conservative unless symptoms are distressing. Botulinum toxin injections may be considered as a first\u2010line treatment if treatment is necessary. Medications such as clonazepam have also been used. For women who are pregnant or lactating, nonpharmacologic management is usually preferred, and any intervention must balance risks versus benefits due to limited safety data on botulinum toxin during pregnancy. Option A (Disappear with sleep) correctly describes a distinguishing feature of essential palatal myoclonus. Option B (Hypertrophy of ipsilateral olivary nucleus) and Option C (Pathology involving triangle of Mollaret) are associated with symptomatic palatal tremor, not the essential variety. 1. Essential palatal tremor typically vanishes during sleep. 2. Audible clicking is a common feature due to muscle contractions. 3. MRI helps distinguish essential from symptomatic forms by assessing for olivary hypertrophy. Recent neuroimaging and clinical studies have reinforced the clinical diagnostic criteria that include resolution during sleep for essential palatal tremor, and treatments like botulinum toxin injections have been further refined for symptomatic relief in refractory cases.",
    "exam_year": "2018",
    "exam_type": "Part I"
  }
]